Mounjaro becomes India’s top-selling drug as patients shift to GLP-1 injections
Mounjaro recorded sales of ₹1,256 crore in the 12 months ending August 2026, up 502 per cent from the previous year
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)